Press release
Gastric Cancer Pipeline Landscape Analysis of 230+ Companies by DelveInsight | Leading Players- Novartis, Genentech, and Others
The Gastric Cancer pipeline report also provides the analysis of the inactive product (dormant and terminated) along with the reasons for dormancy and discontinuation, wherever available. This report provides detailed profiles of the pipeline assets and a comparative analysis of clinical and non-clinical stage products.
Gastric Cancer Overview
Stomach cancer is cancer that starts anywhere inside the stomach or the stomach wall. It's also called gastric cancer. Stomach cancer is more common in older people. Around 50 out of 100 cases (around 50%) occur in people aged 75 or over. It is more common in men than women. Many stomach cancers are linked to lifestyle or environmental factors, including diet. Stomach cancer is linked with a bacteria that lives in the stomach called Helicobacter pylori. But not everyone with Helicobacter pylori will develop stomach cancer. The most common symptoms of stomach cancer include: difficulty swallowing (dysphagia), weight loss, indigestion (dyspepsia) that doesn't go away, feeling full after eating small amounts, feeling or being sick, and tiredness due to low red blood cells (anaemia). There are different types of treatment for patients with gastric cancer. Seven types of standard treatment are used: Surgery, Endoscopic mucosal resection, Chemotherapy, Radiation therapy, Chemoradiation, Targeted therapy, and Immunotherapy.
Download Sample Report- https://www.delveinsight.com/sample-request/gastric-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Gastric Cancer Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into companies that are developing therapies in the Gastric Cancer Market.
• It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Gastric Cancer treatment.
• Gastric Cancer key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Gastric Cancer Drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Gastric Cancer market.
The report is built using data and information traced from the researcher proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Gastric Cancer Emerging Drugs
• IBI308: Innovent Biologics
• HLX10: Henlix Biotech
• Pamiparib: BeiGene
Gastric Cancer Pipeline Therapeutics Analysis
There are approx. 230+ key companies which are developing the therapies for Gastric Cancer. The companies which have their Gastric Cancer drug candidates in the most advanced stage, i.e. phase III include, Innovent Biologics.
Gastric Cancer Pipeline Phases
DelveInsight's report covers around 230+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Gastric Cancer Pipeline Companies
• Hutchison Medipharma Limited
• EMD Serono
• Sumitomo Pharma
• Jiangsu HengRui Medicine Co., Ltd.
• LintonPharm Co.,Ltd.
• Rapa Therapeutics LLC
• Jiangsu HengRui Medicine Co., Ltd.
• Eli Lilly and Company
• Janssen Pharmaceutical K.K.
• Hoffmann-La Roche
• Novartis
• Genentech
• Exelixis
• Bristol-Myers Squibb
• Pieris Pharmaceuticals, Inc.
• Pfizer
• Leap Therapeutics
• CSPC ZhongQi Pharmaceutical
• Ellipses Pharma
• Merck Sharp & Dohme LLC
• Amgen
• Hanmi Pharmaceutical
• Taiho Oncology, Inc.
• Merck KGaA
• Shanghai Henlius Biotech
• Shanghai Henlius Biotech
• LianBio LLC
• Chengdu Kanghong Biotech
• Merck Sharp & Dohme LLC
• AB Science
• Maxinovel
• Shanghai Miracogen Inc.
• Shanghai Miracogen Inc.
• GlaxoSmithKline
• Hoffmann-La Roche
• Merck Sharp & Dohme
• Bayer
• Hutchison Medipharma Limited, and several others
Gastric Cancer Emerging Drugs Chapters
This segment of the Gastric Cancer report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.
Gastric Cancer Pipeline Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Gastric Cancer Pipeline Report Highlights
The companies and academics are working to assess challenges and seek opportunities that could influence Gastric Cancer R&D. The therapies under development are focused on novel approaches to treat/improve Gastric Cancer.
Request Sample Report- https://www.delveinsight.com/sample-request/gastric-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Gastric Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. IBI308: Innovent Biologics
8. Mid Stage Products (Phase II)
9. Pamiparib: BeiGene
10. Early Stage Products (Phase I)
11. HC 5404 FU: HiberCell
12. Preclinical and Discovery Stage Products
13. PolyPEPI 1311: Treos Bio
14. Inactive Products
15. Gastric Cancer Key Companies
16. Gastric Cancer Key Products
17. Gastric Cancer- Unmet Needs
18. Gastric Cancer- Market Drivers and Barriers
19. Gastric Cancer- Future Perspectives and Conclusion
20. Gastric Cancer Analyst Views
21. Gastric Cancer Key Companies
22. Appendix
Do you have any query related to the report? If yes, visit here- https://www.delveinsight.com/report-store/gastric-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Pipeline Landscape Analysis of 230+ Companies by DelveInsight | Leading Players- Novartis, Genentech, and Others here
News-ID: 2762103 • Views: …
More Releases from DelveInsight Business Research
Autotransfusion Systems Market is Expected to Reach USD 816.35 million by 2032 | …
The global Autotransfusion Systems Market is witnessing steady growth as healthcare systems worldwide continue to prioritize patient safety, blood conservation, and advanced surgical efficiency. According to DelveInsight's latest report, the market was valued at USD 512.82 million in 2024 and is projected to reach USD 816.35 million by 2032, expanding at a CAGR of 6.04% during the forecast period (2025-2032).
Autotransfusion systems are gaining traction across hospitals and surgical centers due…
Global Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market t …
According to DelveInsight's latest report, "Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type, Power Source, End-User, and Geography," the global market is projected to grow at a steady compound annual growth rate (CAGR) of 5.36% during the forecast period from 2025 to 2032. The market, valued at USD 150.65 million in 2024, is anticipated to reach USD 227.88 million by 2032, driven by the increasing prevalence of cardiovascular…
Global Airway Management Devices Market is Expected to Reach USD 2.29 billion by …
The global Airway Management Devices Market is on a robust growth trajectory, projected to expand from USD 1.60 billion in 2023 to USD 2.29 billion by 2032, growing at a steady CAGR of 6.21% during the forecast period (2025-2032). The increasing prevalence of respiratory disorders such as asthma, COPD, and airway obstructions, along with a rise in surgical procedures and worsening air pollution, are among the primary factors fueling market…
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials …
Cartilage Diseases Market Analysis 2032 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Cartilage Diseases companies are Regeneron, TissueGene, Vericel Corporation, Genzyme Corporation, Eli Lilly and Company, Incyte Corporation, Astellas Pharma, Pfizer, Sanofi, among others. Promising Cartilage Diseases therapies are Olumiant (Baricitinib), Celebrex (Celecoxib), Motrin (Ibuprofen), Kevzara (Sarilumab), and others.
DelveInsight's "Cartilage Diseases Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of…
More Releases for Gastric
Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Cancer Drugs Market Size By 2025?
In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
